Cardiogenics Holding (CGNH) 0.0200 $CGNH
USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application
GlobeNewswire - Tue Feb 17, 8:50AM CST
CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD"
testing market, announced today that the United States Patent & Trademark Office ("USPTO" has issued a Notice of Allowance with respect to certain patent claims contained in its patent application for the self-metering cartridge to be utilized in the Company's QL Care(TM) analyzer. The Notice of Allowance, which is the USPTO's notice to the Company that the allowed patent claims are entitled to patent protection, now clears the way for the issuance of the patent for the self-metering cartridge, upon payment of the applicable patent issuance fees.
InsiderInsights.com Daily Round Up 2/11/15: GRUB, FSC, RENT, SXC
InsiderInsights - at Seeking Alpha - Thu Feb 12, 11:02AM CST
GRA: 102.35 (+2.50), GRUB: 31.21 (-0.35), SXC: 12.01 (-0.35), RENT: 67.72 (-0.13), ASPX: 100.96 (unch), BH: 427.78 (-1.32), NOW: 76.74 (+0.56), FSC: 6.54 (+0.05), NWL: 41.83 (+1.11), AST: 4.24 (+0.22), AVNU: 12.91 (+0.04), WDR: 45.03 (+0.69), DATA: 121.01 (+1.56), CRM: 71.14 (+1.18)
CardioGenics Announces Appointment of New Director
GlobeNewswire - Mon Jan 12, 3:30PM CST
CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics testing market, announced today that Karim Murabet has been appointed as a director of the Company, effective January 12, 2015. Mr. Murabet will serve as an independent director.
USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application
GlobeNewswire - Tue Feb 17, 8:50AM CST
CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD"
testing market, announced today that the United States Patent & Trademark Office ("USPTO" has issued a Notice of Allowance with respect to certain patent claims contained in its patent application for the self-metering cartridge to be utilized in the Company's QL Care(TM) analyzer. The Notice of Allowance, which is the USPTO's notice to the Company that the allowed patent claims are entitled to patent protection, now clears the way for the issuance of the patent for the self-metering cartridge, upon payment of the applicable patent issuance fees. InsiderInsights.com Daily Round Up 2/11/15: GRUB, FSC, RENT, SXC
InsiderInsights - at Seeking Alpha - Thu Feb 12, 11:02AM CST
GRA: 102.35 (+2.50), GRUB: 31.21 (-0.35), SXC: 12.01 (-0.35), RENT: 67.72 (-0.13), ASPX: 100.96 (unch), BH: 427.78 (-1.32), NOW: 76.74 (+0.56), FSC: 6.54 (+0.05), NWL: 41.83 (+1.11), AST: 4.24 (+0.22), AVNU: 12.91 (+0.04), WDR: 45.03 (+0.69), DATA: 121.01 (+1.56), CRM: 71.14 (+1.18)
CardioGenics Announces Appointment of New Director
GlobeNewswire - Mon Jan 12, 3:30PM CST
CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics testing market, announced today that Karim Murabet has been appointed as a director of the Company, effective January 12, 2015. Mr. Murabet will serve as an independent director.
